Markets regulator Sebi on Friday gave certain relaxations to non-resident Indians in respect of holding of depository receipts (DRs) issued by India-listed companies.
NRIs can now hold DRs issued by the company under the employee stock option schemes, bonus issue and rights issue, the regulator said.
In October 2019, theSecurities and Exchange Board of India (Sebi) barred NRIs from buying DRs issued by India-listed companies.
This restriction will not apply in the case of issue of DRs to NRIs, pursuant to share-based employee benefit schemes that are implementedby a company in terms of Sebi (Share Based Employee Benefits) rules, the regulator said in a circular on Friday.
In addition, the restriction would also not apply in the case of issue of DRs by the company to NRIs following a bonus issue or a rights issue, it added.
“Except as permitted under the provisos above, NRIs shall neither subscribe to any further issue of DRs nor make any further acquisition of DRs (including of DRs issued prior to October 10, 2019),” Sebi clarified.
It further said the onus of identification of NRI holders, who are issued DRs in terms employee benefit scheme, would lie with the listed company.
The company would provide the information of such NRI DR holders to the designated depository for the purpose of monitoring of limits, Sebi said.
Depository receipt is a foreign currency-denominated instrument, listed on an international exchange, issued by a foreign depository to a domestic custodian and includes global depository receipts (GDRs).
“The recent circular of Sebi providing clarification on the framework for issuance of DRs provides a breather for companies exploring listing/listed in overseas exchanges and compensating their employees with ESOPS or announcing bonus/rights to existing shareholders,” said Divam Sharma, co-founder at Green Portfolio, a Sebi-registered portfolio management services firm.
Considering that many shareholders of these companies remain resident Indians or NRIs, this clarification gives them access to the DR route for being compensated as an employee or early investor with the company, he added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
